# Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae

> **NCT02005159** · — · COMPLETED · sponsor: **Fundación Pública Andaluza Progreso y Salud** · enrollment: 1064 (actual)

## Conditions studied

- Bacteremia by Enterobacteriaceae

## Interventions

- **OTHER:** Microbiological studies

## Key facts

- **NCT ID:** NCT02005159
- **Lead sponsor:** Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1064 (ACTUAL)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005159, "Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02005159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*